Aliri Bioanalysis

Aliri Bioanalysis is a global contract research organization (CRO) based in Colorado, specializing in bioanalytical and spatial multi-omics solutions for drug development. With over 30 years of experience, Aliri supports biotech and pharmaceutical clients in advancing molecules from discovery through clinical development and regulatory approval. The company employs between 51 and 200 people and focuses on operational excellence and innovative technologies. Aliri offers a comprehensive range of services throughout the drug development lifecycle. Their bioanalytical services include drug optimization, pharmacodynamic efficacy analysis, and patient stratification using advanced mass spectrometry. They also utilize spatial imaging and multi-omics approaches to evaluate drug efficacy at cellular and tissue levels. Additionally, Aliri provides regulatory support for submissions like Investigational New Drug (IND) and New Drug Application (NDA), ensuring compliance with regulatory requirements. Their expertise helps clients navigate technical challenges and optimize programs to enhance the efficiency of bringing therapies to market.